World Biosimilar Congress

 

2-5 November 2020 | Live Digital 

 

 

1,800+
Attendees
700+
1-2-1 Meetings
300+
Speakers
100+
Exhibitors
3
Co-located events

Sessions you can't miss

Where next with biosimilars in Oncology?

• How successful has adoption of Bio-similars in cancer been in the UK
• What should now guide our decision making about choice of biosimilar
• Is the future a switch every couple of years?

Robert Duncombe , Director of Pharmacy , The Christie NHS Foundation Trust

Fireside Chat

 
 

Raman Singh , CEO , Mundipharma

PANEL DISCUSSION: The path to sustainability: biosimilars in the US vs the EU?

• Chair: Steven Lehrer, Senior Management Advisor, SBLehrer LLC
• Chad Pettit, Executive Director Global Value Access and Policy, Amgen
• Margaret Rehayem, Director Initiatives & Programmes, National Alliance of Healthcare Purchaser Coalitions
• Isabell Remus, Head, Biopharmaceuticals Europe, Sandoz

Peter Senter , VP, Distinguished Research Fellow , Seattle Genetics

Festibval of Biologics

 

There are two parts to the Festival of Biologics: three conferences covering Antibodies, Immunotherapy, Biosimilars and an exhibition featuring solutions for pharma and biotech.